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BACKGROUND ABSORB EXTEND is a global continued access study
that followed the First-In-Man ABSORB trial. It is aimed at expanding
experience with Absorb bioresorbable everolimus eluting vascular
scaffold (Absorb BVS, Abbott Vascular, Santa Clara, CA, US) to more
geographies and to a larger population of patients, including patients
treated for longer lesions using planned overlapping of scaffolds.
Interim analyses from ABSORB EXTEND have shown the safety and
efﬁcacy of Absorb BVS for the ﬁrst 450 subjects up to 2 years with low
target lesion failure and scaffold thrombosis rates (6.5% and 1.1%,
respectively). The Optical Coherence Tomography (OCT) imaging sub-
study is being conducted within this trial to assess the outcomes
associated with planned overlapping of Absorb BVS.
METHODS A total of 812 patients were enrolled from 56 global sites in this
prospective, single-arm, open-label clinical study. Patients with lesions 
28 mm in length and reference vessel diameter of 2.0 - 3.8 mm were
included with treatment of a maximum of two de novo native coronary
artery lesions, each in a different epicardial vessel. A subset of 14 patients
(designated as the OCT subgroup) who received planned overlapping of
Absorb BVS at designated OCT sites will be assessed using OCT, angiog-
raphy and intravascular ultrasound imaging post-procedure and at 2 years.
RESULTS The mean age of this OCT subgroup was 62.01 years and
85.7% were male. 14.3% of patients had a history of previous MI and
14.3% had a prior cardiac intervention. The mean lesion length was
15.22mm.About 25%of the lesionswere longer than 20mm.Despite the
use of planned overlapping of Absorb BVS, clinical device and proce-
dure success rates were both 100%. OCT and other imaging outcomes
from post-procedure and at 2-year follow-up will be reported.
CONCLUSION The treatment with planned overlapping of Absorb BVS
was highly successful in this small cohort of OCT subgroup patients.
The 2-year imaging results will provide further information on the
feasibility and long term outcomes of longer lesion treatment using
planned overlapping of Absorb BVS.
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BACKGROUND The relative failure of PCI in proximal LAD compared to
CABG remains an important challenge for interventional cardiologists.
Numerous trials comparing CABG to PCI in proximal LAD from the
balloon angioplasty toBMS toDES era, demonstrated that CABGhas less
TVF rates compared to PCI driven by less repeat revascularizations in
theCABGarm. IVUS-guided PCI trials clearly suggest that patients in the
IVUS - guided arm consistently had stents which were larger in diam-
eter. This led us to think that the possible cause of failure in the prox-
imal LAD could be because of under-sizing of the proximal LAD by
Quantitative Coronary Angiography.We set out to test this fact by doing
simultaneous IVUS and QCA measurements of the proximal LAD in a
series of 50 patients undergoing PCI to the LAD. We present illustrative
QCA and IVUS images of a patient to demonstrate our contention.METHODS The proximal LAD was deﬁned as the segment of LAD be-
tween the ostium and the ﬁrst diagonal artery. Simultaneous QCA and
motorized IVUS-pullback studies using ATLANTIS PRO 40Mhz IVUS
probe were done in all patients undergoing PCI to LAD. We measured
the LAD diameter at the ostium, and prior to its bifurcation with the
ﬁrst diagonal by IVUS .Two cross-sectional measurements of the LAD
were done at each point .We took an average of these four values to
arrive at the diameter of the proximal LAD. These values were then
compared to the maximum QCA value obtained along the length of
the proximal LAD.
